Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Scientist Who Led Genentech to Avastin Joins Tiziana as Adviser

May 19 (Bloomberg) -- Napoleone Ferrara, professor at UC San Diego School of Medicine, joins Tiziana Life Sciences as chairman of scientific advisory board and consultant, co. says in statement. * Co. developing experimental treatment for late-stage breast cancer targeting BCL3 gene * “I look forward to advising the company’s scientists as they work towards human trials for this promising therapeutic gene technology”: Ferrara * NOTE: Tiziana started trading on AIM on April 24 * NOTE: Ferrara in 2010 won Lasker Award, which often foretells future Nobel Prize winners * NOTE: Avastin for colorectal, breast, lung, kidney, ovarian cancers and glioblastoma had CHF6.25b ($7b) in sales last yr

To contact the reporter on this story: Makiko Kitamura in London at

To contact the editors responsible for this story: Phil Serafino at Kristen Hallam, Tom Lavell

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.